Sequent Research Profile
Key Indicators
- Authorised Capital ₹ 4.70 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.41 Cr
as on 24-10-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 32.85 Cr
as on 24-10-2024
- Revenue -36.05%
(FY 2023)
- Profit -152.82%
(FY 2023)
- Ebitda -93.38%
(FY 2023)
- Net Worth -16.25%
(FY 2023)
- Total Assets -7.95%
(FY 2023)
About Sequent Research
The Corporate was formerly known as Sequent Research Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.70 Cr and a paid-up capital of Rs 4.41 Cr.
The company has closed loans amounting to ₹32.85 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajaram Narayanan, Prasad Lad, Saurav Bhala, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232KA2007PLC042483
- Company No.
042483
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2007
- Date of AGM
30 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Dakshina Kannada, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sequent Research?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajaram Narayanan  | Director | 11-Apr-2022 | Current |
| Prasad Lad | Director | 24-May-2022 | Current |
| Saurav Bhala | Additional Director | 25-Apr-2024 | Current |
| Vedprakash Ragate | Additional Director | 13-Jun-2024 | Current |
Financial Performance and Corporate Structure Insights of Sequent Research.
Sequent Research Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.05% decrease. The company also saw a substantial fall in profitability, with a 152.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sequent Research?
In 2022, Sequent Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alivira Animal Health LimitedActive 11 years 2 monthsRajaram Narayanan and Vedprakash Ragate are mutual person
Sequent Scientific LimitedActive 39 years 5 monthsRajaram Narayanan and Vedprakash Ragate are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jun 2015 | ₹11.05 Cr | Satisfied |
Housing Development Finance Corporation Limited Creation Date: 20 Dec 2012 | ₹12.00 Cr | Satisfied |
Corporation Bank Creation Date: 24 Oct 2007 | ₹9.80 Cr | Satisfied |
How Many Employees Work at Sequent Research?
Sequent Research has a workforce of 52 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sequent Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequent Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
